Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $39.4000 (4.23%) ($38.0000 - $40.5000) on Tue. Jan. 13, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.04% (three month average) | RSI | 66 | Latest Price | $39.4000(4.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2.3% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) JNK(7%) PEJ(7%) VT(7%) XLF(7%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.02% in a week (0% probabilities). VIXM(-5%) TLT(-3%) SLV(-2%) GLD(-2%) BND(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.02% (StdDev 4.04%) | Hourly BBV | 0 () | Intraday Trend | 3.7% | | | |
|
5 Day Moving Average | $36.58(7.71%) | 10 Day Moving Average | $36.82(7.01%) | 20 Day Moving Average | $36.47(8.03%) | To recent high | -7.1% | To recent low | 15.9% | Market Cap | $776m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |